Listed

IGC Pharma, Inc.: Form 10-K for the period ended Mar 31, 2017

Filed with the SEC on Jul 14, 2017 and accepted by EDGAR at Jul 13, 2017, 21:26 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2016-04-01 to 2017-03-31$580.4kus-gaap:Revenues
Cost of revenue12 months2016-04-01 to 2017-03-31$362.1kus-gaap:CostOfRevenue
Selling, general and administrative12 months2016-04-01 to 2017-03-31$1.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2016-04-01 to 2017-03-31−$2.1mus-gaap:OperatingIncomeLoss
Interest expense12 months2016-04-01 to 2017-03-31$223.5kus-gaap:InterestExpense
Income tax12 months2016-04-01 to 2017-03-31$14.4kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2016-04-01 to 2017-03-31−$1.9mus-gaap:NetIncomeLoss
Diluted EPS12 months2016-04-01 to 2017-03-31−$0.07us-gaap:EarningsPerShareDiluted
Basic EPS12 months2016-04-01 to 2017-03-31−$0.07us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2016-04-01 to 2017-03-3125,658,544 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2016-04-01 to 2017-03-31−$1.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2016-04-01 to 2017-03-31$145.7kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2017-03-31$538.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-03-31$3.6mus-gaap:AssetsCurrent
Total assetsAt period end2017-03-31$11.3mus-gaap:Assets
Current liabilitiesAt period end2017-03-31$1.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-03-31$3.9mus-gaap:Liabilities
Long-term debtAt period end2017-03-31$452.1kus-gaap:LongTermDebtNoncurrent
Short-term borrowingsAt period end2017-03-31$0us-gaap:ShortTermBorrowings
Shareholders' equityAt period end2017-03-31$7.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001185185-17-001544. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.